摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Propanaminium, N,N,N-trimethyl-2,3-bis[(1-oxohexadecyl)oxy]- | 138915-91-0

中文名称
——
中文别名
——
英文名称
1-Propanaminium, N,N,N-trimethyl-2,3-bis[(1-oxohexadecyl)oxy]-
英文别名
2,3-di(hexadecanoyloxy)propyl-trimethylazanium
1-Propanaminium, N,N,N-trimethyl-2,3-bis[(1-oxohexadecyl)oxy]-化学式
CAS
138915-91-0
化学式
C38H76NO4+
mdl
——
分子量
611.0
InChiKey
PBIYEBPNYDHBDF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    14.8
  • 重原子数:
    43
  • 可旋转键数:
    35
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.95
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Methods and compositions for the efficient delivery of therapeutic agents to cells and animals
    申请人:Rana M. Tariq
    公开号:US20070260055A1
    公开(公告)日:2007-11-08
    The present invention provides methods of carrying out the safe and reliable preparation of lipids comprising quaternary amines. Such lipids are especially suited for introducing therapeutic agents into cells or organisms. In particular, the lipids of the invention are suitable for the efficient transfer of gene therapy agents into mammalian cells or organisms in a cell type specific or tissue specific manner.
    本发明提供了一种安全可靠的制备含季铵盐脂质的方法。这种脂质特别适合将治疗剂介入细胞或生物体中。特别是,本发明的脂质适用于以细胞类型特异性或组织特异性的方式高效地将基因治疗剂转移到哺乳动物细胞或生物体中。
  • Formulation containing TLR agonist and methods of use
    申请人:ACCESS TO ADVANCED HEALTH INSTITUTE
    公开号:US11344619B2
    公开(公告)日:2022-05-31
    Stable aqueous formulations of adjuvant comprising a TLR7/8 agonist or a TLR4 agonist with a helper lipid that are adsorbed to alum are provided. Compositions and methods of using the formulations for stimulating an immune response are also provided.
    提供了由 TLR7/8 激动剂或 TLR4 激动剂与辅助脂质组成的吸附于明矾的稳定佐剂水性制剂。还提供了使用这些制剂刺激免疫反应的组合物和方法。
  • Formulation Containing TLR Agonist and Methods of Use
    申请人:Infectious Disease Research Institute
    公开号:US20190142935A1
    公开(公告)日:2019-05-16
    Stable aqueous formulations of adjuvant comprising a TLR7/8 agonist or a TLR4 agonist with a helper lipid that are adsorbed to alum are provided. Compositions and methods of using the formulations for stimulating an immune response are also provided.
  • US8329681B2
    申请人:——
    公开号:US8329681B2
    公开(公告)日:2012-12-11
查看更多